BACKGROUND/AIMS: A potential application of gliotoxin therapy for liver fibrosis was suggested by its apoptotic effect on fibrogenic activated stellate cells. We investigated if gliotoxin exerts similar effects on hepatic macrophage Kupffer cells. METHODS: Effects of gliotoxin on Kupffer cells isolated from the normal liver and in vivo following its administration to CCl(4)-induced cirrhotic rats were studied. RESULTS: Gliotoxin caused apoptosis of cultured Kupffer cells, the effect being apparent at 0.3 microM concentration within 1h; longer incubation caused necrosis. This effect was associated with mitochondrial cytochrome c release, caspase-3 activation and ATP depletion. Interestingly, inhibition of caspase-3 and serine proteases accelerated and augmented gliotoxin-induced cell death via necrosis. Gliotoxin stimulated nuclear translocation of NFkappaB, and phosphorylation of p38, ERK1/2 and JNK MAP kinases, but these signaling molecules were not involved in gliotoxin-induced death of Kupffer cells. In vivo administration of gliotoxin to cirrhotic rats caused apoptosis of Kupffer cells, stellate cells and hepatocytes. In control rats, the effect was minimal on the nonparenchymal cells and not apparent on hepatocytes. CONCLUSIONS: In the fibrotic liver, gliotoxin nonspecifically causes death of hepatic cell types. Modification of gliotoxin molecule may be necessary for selective targeting and elimination of activated stellate cells.
BACKGROUND/AIMS: A potential application of gliotoxin therapy for liver fibrosis was suggested by its apoptotic effect on fibrogenic activated stellate cells. We investigated if gliotoxin exerts similar effects on hepatic macrophage Kupffer cells. METHODS: Effects of gliotoxin on Kupffer cells isolated from the normal liver and in vivo following its administration to CCl(4)-induced cirrhotic rats were studied. RESULTS:Gliotoxin caused apoptosis of cultured Kupffer cells, the effect being apparent at 0.3 microM concentration within 1h; longer incubation caused necrosis. This effect was associated with mitochondrial cytochrome c release, caspase-3 activation and ATP depletion. Interestingly, inhibition of caspase-3 and serine proteases accelerated and augmented gliotoxin-induced cell death via necrosis. Gliotoxin stimulated nuclear translocation of NFkappaB, and phosphorylation of p38, ERK1/2 and JNK MAP kinases, but these signaling molecules were not involved in gliotoxin-induced death of Kupffer cells. In vivo administration of gliotoxin to cirrhotic rats caused apoptosis of Kupffer cells, stellate cells and hepatocytes. In control rats, the effect was minimal on the nonparenchymal cells and not apparent on hepatocytes. CONCLUSIONS: In the fibrotic liver, gliotoxin nonspecifically causes death of hepatic cell types. Modification of gliotoxin molecule may be necessary for selective targeting and elimination of activated stellate cells.
Authors: James G Orr; Val Leel; Gary A Cameron; Carylyn J Marek; Emma L Haughton; Lucy J Elrick; Julie E Trim; Gabrielle M Hawksworth; Andrew P Halestrap; Matthew C Wright Journal: Hepatology Date: 2004-07 Impact factor: 17.425
Authors: Chinnasamy Thirunavukkarasu; Simon Watkins; Stephen A K Harvey; Chandrashekhar R Gandhi Journal: J Hepatol Date: 2004-10 Impact factor: 25.083
Authors: Glaucia R Martinez; Ana Paula M Loureiro; Sabrina A Marques; Sayuri Miyamoto; Lydia F Yamaguchi; Janice Onuki; Eduardo A Almeida; Camila C M Garcia; Lívea F Barbosa; Marisa H G Medeiros; Paolo Di Mascio Journal: Mutat Res Date: 2003-11 Impact factor: 2.433
Authors: Angela Douglass; Karen Wallace; Matthew Koruth; Caroline Barelle; Andrew J Porter; Matthew C Wright Journal: Hepatol Int Date: 2008-09-03 Impact factor: 6.047
Authors: Juan E Puche; Youngmin A Lee; Jingjing Jiao; Costica Aloman; Maria I Fiel; Ursula Muñoz; Thomas Kraus; Tingfang Lee; Hal F Yee; Scott L Friedman Journal: Hepatology Date: 2013-01 Impact factor: 17.425
Authors: Rachel K Stewart; Anil Dangi; Chao Huang; Noriko Murase; Shoko Kimura; Donna B Stolz; Gregory C Wilson; Alex B Lentsch; Chandrashekhar R Gandhi Journal: J Hepatol Date: 2013-09-20 Impact factor: 25.083